Kalshi unveiled a pilot program in partnership with AppliedXL to launch prediction markets focused on clinical trial outcomes and FDA regulatory decisions. The exchange will publish continuously updated probabilities intended to reflect public evidence rather than sponsor messaging, aiming to reduce information asymmetry in drug development.